# Oxcarbazepine

## Trileptal 60mg/mL 100mL oral suspension

| 藥物代碼 | LTRIL |
| :--- | :--- |
| 適應症 | Epilepsy: Partial & generalized tonic-clonic seizures. |
| 副作用 | Somnolence, headache, dizziness; diplopia; vomiting, nausea; fatigue. Hyponatremia; agitation, affect lability, confusional state, depression, apathy; ataxia, tremor, nystagmus, disturbance in attention, amnesia; blurred vision, visual disturbance; vertigo; diarrhea, abdominal pain, constipation; rash, alopecia, acne; asthenia. Children 1 mth to &lt;4 yr: Ataxia, irritability, vomiting, lethargy, fatigue, nystagmus, tremor, decreased appetite & increased blood uric acid. |
| 禁忌 | Hypersensitivity. |
| 藥物保存方式 | 室溫 |
| 用法用量 | -Adult & elderly Mono- & adjunctive therapy: 600 mg/day \(8-10 mg/kg/day\) in 2 divided doses. Maintenance: 600 mg/day & 2,400 mg/day. May be increased by a max of 600 mg/day increments at approx wkly intervals. Max: 2,400 mg/day over 48 hr in a controlled hospital setting. -Childn Mono-& adjunctive therapy: 8-10 mg/kg/day in 2 divided doses. Maintenance: 30-46 mg/kg/day for adjunctive therapy for over 2 wk. May be increased by a max of 10 mg/kg/day increments at approx wkly intervals from starting dose to max daily dose of 60 mg/kg/day. -Renal impairment CrCl &lt;30 mL/min Start at 300 mg/day & increase slowly to achieve the desired clinical response. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 需 調 整 劑 量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | AC, AC15, PC, PO, WM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

## Trileptal 300mg

| 藥物代碼 | OTRIL |
| :--- | :--- |
| 適應症 | Monotherapy & adjunctive treatment of partial seizures in adult. Adjunctive treatment of partial seizure in children &lt;1 month. |
| 副作用 | Frequent: Fatigue, dizziness, headache, somnolence, nausea, vomiting, diplopia. Common: Asthenia, agitation, amnesia, apathy, ataxia, impaired concentration, confusion, depression, emotional lability, nystagmus, tremor, constipation, diarrhea, abdominal pain, asymptomatic hyponatremia, acne, alopecia, rash, vertigo, vision disorders. Uncommon: Leucopenia, increase in liver enzyme, urticaria. Very rare: Angioedema, multi-organ hypersensitivity disorders, arrhythmia, thrombocytopenia, hepatitis, symptomatic hyponatremia, Stevens-Johnson syndrome, SLE. |
| 禁忌 | Hypersensitivity. |
| 藥物保存方式 | 室溫 |
| 用法用量 | Adult 600-2400 mg/day in 2 divided doses. Children Initially 8-10 mg/kg/day in 2 divided doses. Dosage may be increased according to response in steps of up to 10 mg/kg daily at weekly intervals. Max: 46 mg/kg daily in divided doses. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 需 調 整 劑 量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

